Table of Contents
- The Study That Caught My Attention
- What They Found
- Why This Matters Clinically
- This Is the Shift Happening in Orthopedics
- What I'm Seeing in Practice
- The Most Important Part of This Entire Conversation
- What the Future Looks Like
- This Is Exactly Why We Created These Trainings
- Join Us at the Regen Summit
- Continue Learning Weekly Inside Our MIT Skool Community

Do not index
If you treat shoulder patients long enough, you start seeing the same cycle over and over again. Pain. Weakness. Limited motion. Physical therapy helps until it doesn't. Steroid injections calm things down temporarily. Then eventually the conversation shifts toward surgery.
What if we started thinking differently about tendon healing altogether? One study I reviewed this week highlights something extremely important for providers who are serious about regenerative medicine.
The Study That Caught My Attention
The article titled Cryopreserved Amniotic Membrane and Umbilical Cord Particulate Matrix for Partial Rotator Cuff Tears: A Case Series looked at patients with partial rotator cuff tears that had failed conservative care. These were not patients who just had shoulder soreness for a few weeks. These were patients who continued to struggle despite standard approaches.
Researchers evaluated the use of cryopreserved amniotic membrane and umbilical cord particulate matrix, referred to as AM/UC, as an intra-articular treatment approach. The outcomes were very interesting.
What They Found
At 6 months, Penn Shoulder Scores improved dramatically. Pain scores improved by 78.4%. Functional scores improved by 82.3%. Satisfaction improved by 37.1%. Range of motion improved from 77.9% to 99.9%. No adverse events were reported.
Let me say this clearly: This was a small case series, not a large randomized trial. However, this is exactly how many major shifts in medicine begin. You start seeing signals. You start seeing patterns.
Why This Matters Clinically
The shoulder is complicated. Rotator cuff pathology is not just a tear problem. It's often chronic degeneration, failed healing response, persistent inflammatory signaling, and mechanical overload combined with biologic insufficiency.
This is where biologic therapies become fascinating. Amniotic membrane and umbilical cord tissue contain extracellular matrix components, cytokines, growth factors, and heavy-chain hyaluronic acid complexes associated with anti-inflammatory activity. That's a very different conversation than simply suppressing pain.
This Is the Shift Happening in Orthopedics
For years, orthopedic medicine has largely focused on stabilizing joints, reducing pain, and operating if necessary. Regenerative medicine is forcing us to ask a different question: Can we improve the biologic environment enough to support healing and function? That's a massive shift in how we approach patient care.

What I'm Seeing in Practice
Providers are starting to realize something important. Patients don't just want temporary relief anymore. They want better function, faster recovery, fewer medications, and options besides surgery. When you begin integrating orthobiologics appropriately, the patient conversation changes entirely.
The Most Important Part of This Entire Conversation
Let me be very direct. Regenerative medicine is not magic. It should never be presented that way. Patient selection matters. Diagnosis matters. Protocols matter. Rehab matters. When you combine biologic understanding with proper clinical application, you start practicing at a completely different level.
What the Future Looks Like
I believe we are moving toward a future where biologic augmentation becomes more common, orthopedics becomes increasingly regenerative-focused, and providers who understand tissue healing will lead the field. Honestly, we are just getting started with what's possible in this space.
This Is Exactly Why We Created These Trainings
If you want to learn how to properly evaluate and implement regenerative protocols for conditions like rotator cuff tears, tendinopathies, joint degeneration, and orthopedic inflammation, that's exactly what we teach inside My Injection Training. Understanding the study is one thing. Knowing how to apply it safely and effectively in practice is where providers separate themselves from the competition.
Join Us at the Regen Summit
If you want to see where regenerative medicine is heading over the next several years, you need to be in the room. The Regen Summit brings together leading regenerative medicine clinicians, orthopedic innovators, biologic experts, and business and implementation strategies. This is not surface-level education. This is the future of medicine being discussed in real time. Learn more and register at RegenEvent.com.

Continue Learning Weekly Inside Our MIT Skool Community
If you want continuous education and discussion every week, join us inside the My Injection Training Skool platform. Inside, you'll get access to weekly Regen Roundtable discussions, case reviews, protocol conversations, and clinical pearls from providers actively doing this work. The providers who continue learning are the ones who will lead the future of regenerative medicine.
Karen Rea, FNP-BC
Regenerative Medicine Expert | Co-Founder, My Injection Training
Co-Founder, GrowthNP | National Trainer of 3,000+ Medical Providers